ANTIKÖRPER GEGEN CD70

European patent · EP2686347 · In force

Register entry

Publication number
EP2686347
Application number
EP12710486
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 16, 2012
Published
Jan 22, 2014
Granted
May 2, 2018
Protection ends at the latest
Mar 15, 2032
Next annual fee due
Mar 31, 2027
IPC classes
C07K 16/28 (2006.01)
Priority
US 201161453390 P 16.03.2011
US 201161503871 P 01.07.2011
PCT application
PCT/EP2012/054733 16.03.2012
PCT publication
WO2012/123586 20.09.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. May 2, 2018

    Granted

    Published in Swissreg on 02.05.2018

  6. May 2, 2018

    Agent entered

    Representative
    Kirker & Cie S.A., 122, rue de Genève, Case postale 90, 1226 Geneve-Thônex

    Published in Swissreg on 02.05.2018

Parties

Holder

Argenx BVBA

argenx BVBA

Industriepark 7, 9052 Zwijnaarde, BE

Agent

Kirker & Cie SA

Kirker & Cie S.A.

122, rue de Genève Case postale 90, 1226 Geneve-Thônex

Inventor

SILENCE, Karen

B-3090 Overijse, BE

ULRICHTS, Peter

B-9070 Destelbergen, BE

DE HAARD, Johannes Joseph Wilhelmus

4436 NA Oudelande, NL

DREIER, Torsten

B-9830 Sint-Martems Latem, BE

SAUNDERS, Michael John Scott

B-1190 Brussels, BE

WAJANT, Harald

97270 Kist, DE

GABRIELS, Sofie Maria Elvire

B-9620 Zottegem, BE

MOSHIR, Mahan

B-9041 Oostakker, BE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.